<html>
<head>PUBMED IDs for AMMECR1</head>
<body bgcolor='#C5F0F2'><h1>AMMECR1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10049589/'>Identification and characterization of a highly conserved protein absent in the Alport syndrome (A), mental retardation (M), midface hypoplasia (M), and elliptocytosis (E) contiguous gene deletion syndrome (AMME).</a> March 2  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10828604/'>Identification and characterization of mouse orthologs of the AMMECR1 and FACL4 genes deleted in AMME syndrome: orthology of Xq22.3 and MmuXF1-F3.</a> June 1  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/23520119/'>Xq22.3-q23 deletion including ACSL4 in a patient with intellectual disability.</a> September 10  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24646681/'>A highly conserved family of domains related to the DNA-glycosylase fold helps predict multiple novel pathways for RNA modifications.</a> January 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27811305/'>AMMECR1: a single point mutation causes developmental delay, midface hypoplasia and elliptocytosis.</a> November 5  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28089922/'>X-linked elliptocytosis with impaired growth is related to mutated AMMECR1.</a> January 17  2017<br></body></html>
